Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic

被引：1

作者：

Cengiz Seval, Guldane ^{[1
]}

Topcuoglu, Pervin ^{[1
]}

Demirer, Taner ^{[1
]}

机构：

[1] Ankara Univ, Dept Hematol, Fac Med, Ankara, Turkey

来源：

TURKISH JOURNAL OF MEDICAL SCIENCES | 2021年 / 51卷 / 06期

关键词：

COVID-19; SARS-CoV-2; hematological malignancies; HIGH-DOSE CHEMOTHERAPY; MULTIPLE-MYELOMA; BREAST-CANCER; LEUKEMIA; MARROW; TRANSPLANTATION; GUIDELINES; MANAGEMENT; RISK;

D O I：

10.3906/sag-2101-276

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background/aim: The COVID-19 pandemic is a unique challenge to the care of patients with hematological malignancies. We aim to provide supportive guidance to clinicians making individual patients decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited. Conclusion: This review also provides recommendations, which are convenient in evaluating indications for therapy, reducing therapy-associated immunosuppression, and reducing healthcare utilization in patients with specific hematological malignancies in the COVID-19 era. Specific decisions regarding treatment of hematological malignancies will need to be individualized, based on disease risk, risk of immunosuppression, rates of community transmission of SARS-CoV-2, and available local healthcare resources.

引用

页码：2799 / 2809

页数：11

共 35 条

[1] Multiple Myeloma in the Time of COVID-19 [J].

Al Saleh, Abdullah S. ;

Sher, Taimur ;

Gertz, Morie A. .

ACTA HAEMATOLOGICA, 2020, 143 (05) :410-416

[2] The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection [J].

Basler, Michael ;

Lauer, Christoph ;

Beck, Ulrike ;

Groettrup, Marcus .

JOURNAL OF IMMUNOLOGY, 2009, 183 (10) :6145-6150

[3] Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation [J].

Brissot, Eolia ;

Labopin, Myriam ;

Baron, Frederic ;

Bazarbachi, Ali ;

Bug, Gesine ;

Ciceri, Fabio ;

Esteve, Jordi ;

Giebel, Sebastian ;

Gilleece, Maria H. ;

Gorin, Norbert-Claude ;

Lanza, Francesco ;

Peric, Zinaida ;

Ruggeri, Annalisa ;

Sanz, Jaime ;

Savani, Bipin N. ;

Schmid, Christoph ;

Shouval, Roni ;

Spyridonidis, Alexandros ;

Versluis, Jurjen ;

Nagler, Arnon ;

Mohty, Mohamad .

BONE MARROW TRANSPLANTATION, 2021, 56 (03) :532-535

[4]

Brunvand MW, 1996, BONE MARROW TRANSPL, V18, P131

[5] Immunomodulatory drugs and the risk of serious infection in multiple myeloma: systematic review and meta-analysis of randomized and observational studies [J].

Chen, Min ;

Zhao, Yongfeng ;

Xu, Chuanxin ;

Wang, Xian ;

Zhang, Xianping ;

Mao, Benyu .

ANNALS OF HEMATOLOGY, 2018, 97 (06) :925-944

[6]

DEMIRER T, 1995, BONE MARROW TRANSPL, V15, P915

[7]

DEMIRER T, 1995, BONE MARROW TRANSPL, V15, P907

[8] Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic [J].

Di Ciaccio, Pietro ;

McCaughan, Georgia ;

Trotman, Judith ;

Ho, Phoebe Joy ;

Cheah, Chan Y. ;

Gangatharan, Shane ;

Wight, Joel ;

Ku, Matthew ;

Quach, Hang ;

Gasiorowski, Robin ;

Polizzotto, Mark N. ;

Prince, Henry Miles ;

Mulligan, Stephen ;

Tam, Constantine S. ;

Gregory, Gareth ;

Hapgood, Greg ;

Spencer, Andrew ;

Dickinson, Michael ;

Latimer, Maya ;

Johnston, Anna ;

Armytage, Tasman ;

Lee, Cindy ;

Cochrane, Tara ;

Berkhahn, Leanne ;

Weinkove, Robert ;

Doocey, Richard ;

Harrison, Simon J. ;

Webber, Nicholas ;

Lee, Hui-Peng ;

Chapman, Scott ;

Campbell, Belinda A. ;

Gibbs, Simon D. J. ;

Hamad, Nada .

INTERNAL MEDICINE JOURNAL, 2020, 50 (06) :667-679

[9] Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions [J].

Elens, Laure ;

Langman, Loralie J. ;

Hesselink, Dennis A. ;

Bergan, Stein ;

Moes, Dirk Jan A. R. ;

Molinaro, Mariadelfina ;

Venkataramanan, Raman ;

Lemaitre, Florian .

THERAPEUTIC DRUG MONITORING, 2020, 42 (03) :360-368

[10] Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial [J].

Fischer, Kirsten ;

Bahlo, Jasmin ;

Fink, Anna Maria ;

Goede, Valentin ;

Herling, Carmen Diana ;

Cramer, Paula ;

Langerbeins, Petra ;

von Tresckow, Julia ;

Engelke, Anja ;

Maurer, Christian ;

Kovacs, Gabor ;

Herling, Marco ;

Tausch, Eugen ;

Kreuzer, Karl-Anton ;

Eichhorst, Barbara ;

Boettcher, Sebastian ;

Seymour, John F. ;

Ghia, Paolo ;

Marlton, Paula ;

Kneba, Michael ;

Wendtner, Clemens-Martin ;

Doehner, Hartmut ;

Stilgenbauer, Stephan ;

Hallek, Michael .

BLOOD, 2016, 127 (02) :208-215

← 1 2 3 4 →